$SNES
SenesTech, Inc.

2024 Q4 Form 10-Q Financial Statement

#000162828024047314 Filed on November 12, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3
Revenue $482.0K
YoY Change 33.89%
Cost Of Revenue $167.0K
YoY Change -9.24%
Gross Profit $315.0K
YoY Change 78.98%
Gross Profit Margin 65.35%
Selling, General & Admin $1.411M
YoY Change -19.28%
% of Gross Profit 447.94%
Research & Development $451.0K
YoY Change 19.0%
% of Gross Profit 143.17%
Depreciation & Amortization $42.00K
YoY Change 23.53%
% of Gross Profit 13.33%
Operating Expenses $1.862M
YoY Change -12.46%
Operating Profit -$1.547M
YoY Change -20.71%
Interest Expense $5.000K
YoY Change 25.0%
% of Operating Profit
Other Income/Expense, Net $34.00K
YoY Change 750.0%
Pretax Income -$1.513M
YoY Change -22.29%
Income Tax
% Of Pretax Income
Net Earnings -$1.513M
YoY Change -22.29%
Net Earnings / Revenue -313.9%
Basic Earnings Per Share -$2.07
Diluted Earnings Per Share -$2.07
COMMON SHARES
Basic Shares Outstanding 1.034M shares 515.3K shares
Diluted Shares Outstanding 729.4K shares

Balance Sheet

Concept 2024 Q4 2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.518M
YoY Change 17.39%
Cash & Equivalents $2.500M
Short-Term Investments
Other Short-Term Assets $360.0K
YoY Change -6.49%
Inventory $880.0K
Prepaid Expenses $360.0K
Receivables $214.0K
Other Receivables $0.00
Total Short-Term Assets $3.972M
YoY Change 19.78%
LONG-TERM ASSETS
Property, Plant & Equipment $380.0K
YoY Change 21.41%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $58.00K
YoY Change 163.64%
Total Long-Term Assets $477.0K
YoY Change -13.59%
TOTAL ASSETS
Total Short-Term Assets $3.972M
Total Long-Term Assets $477.0K
Total Assets $4.449M
YoY Change 15.02%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $128.0K
YoY Change -12.93%
Accrued Expenses $394.0K
YoY Change -41.28%
Deferred Revenue $12.00K
YoY Change -20.0%
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due $53.00K
YoY Change 488.89%
Total Short-Term Liabilities $628.0K
YoY Change -39.26%
LONG-TERM LIABILITIES
Long-Term Debt $170.0K
YoY Change 286.36%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $170.0K
YoY Change 117.95%
TOTAL LIABILITIES
Total Short-Term Liabilities $628.0K
Total Long-Term Liabilities $170.0K
Total Liabilities $798.0K
YoY Change -28.24%
SHAREHOLDERS EQUITY
Retained Earnings -$134.8M
YoY Change 5.15%
Common Stock $1.000K
YoY Change -66.67%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $3.651M
YoY Change
Total Liabilities & Shareholders Equity $4.449M
YoY Change 15.02%

Cashflow Statement

Concept 2024 Q4 2024 Q3
OPERATING ACTIVITIES
Net Income -$1.513M
YoY Change -22.29%
Depreciation, Depletion And Amortization $42.00K
YoY Change 23.53%
Cash From Operating Activities -$1.399M
YoY Change -21.71%
INVESTING ACTIVITIES
Capital Expenditures $28.00K
YoY Change -70.21%
Acquisitions
YoY Change
Other Investing Activities $28.00K
YoY Change
Cash From Investing Activities $0.00
YoY Change -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 1.965M
YoY Change 7.32%
NET CHANGE
Cash From Operating Activities -1.399M
Cash From Investing Activities 0.000
Cash From Financing Activities 1.965M
Net Change In Cash 566.0K
YoY Change -1232.0%
FREE CASH FLOW
Cash From Operating Activities -$1.399M
Capital Expenditures $28.00K
Free Cash Flow -$1.427M
YoY Change -24.14%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
1033644 shares
CY2024Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
us-gaap Gross Profit
GrossProfit
410000 usd
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
379000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1288000 usd
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2500000 usd
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.07
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity Registrant Name
EntityRegistrantName
SENESTECH, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Address Address Line1
EntityAddressAddressLine1
777 W. Pinnacle Peak Road,
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite B104
dei Entity Address City Or Town
EntityAddressCityOrTown
Phoenix
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-1513000 usd
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
729400 shares
dei Entity Address State Or Province
EntityAddressStateOrProvince
AZ
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
85027
dei City Area Code
CityAreaCode
(928)
dei Local Phone Number
LocalPhoneNumber
779-4143
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1020842 shares
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
482000 usd
CY2024Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
167000 usd
CY2024Q3 us-gaap Gross Profit
GrossProfit
315000 usd
CY2024Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1411000 usd
CY2024Q3 us-gaap Operating Expenses
OperatingExpenses
1862000 usd
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-1547000 usd
CY2024Q3 us-gaap Investment Income Net
InvestmentIncomeNet
11000 usd
CY2024Q3 us-gaap Interest Expense Debt
InterestExpenseDebt
6000 usd
CY2024Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
29000 usd
CY2024Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
34000 usd
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1947000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-1947000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-4929000 usd
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
34805 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
586628 shares
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-55.93
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-8.40
CY2023Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
4000 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
4000 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
6000 usd
CY2023Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
5000 usd
CY2022Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
18000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-1993000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
2827000 usd
us-gaap Gross Profit
GrossProfit
699000 usd
CY2024Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
451000 usd
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
20-2079805
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
34805 shares
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1012549 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
514003 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
514003 shares
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
1000 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
1000 usd
CY2024Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
138492000 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
136263000 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-134842000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-129913000 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
3651000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
6351000 usd
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
4449000 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
7293000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
360000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1356000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
898000 usd
CY2023Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
184000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
657000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
488000 usd
CY2023Q3 us-gaap Gross Profit
GrossProfit
176000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1147000 usd
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1748000 usd
dei Entity Central Index Key
EntityCentralIndexKey
0001680378
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Amendment Flag
AmendmentFlag
false
CY2024Q3 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.10
CY2024Q3 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.10
dei Security12b Title
Security12bTitle
Common Stock, $0.001 par value
dei Trading Symbol
TradingSymbol
SNES
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2518000 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5395000 usd
CY2024Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
214000 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
95000 usd
CY2024Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
360000 usd
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
388000 usd
CY2024Q3 us-gaap Inventory Net
InventoryNet
880000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
795000 usd
CY2024Q3 us-gaap Assets Current
AssetsCurrent
3972000 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
6673000 usd
CY2024Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
39000 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
210000 usd
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
380000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
388000 usd
CY2024Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
58000 usd
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
22000 usd
CY2024Q3 us-gaap Assets
Assets
4449000 usd
CY2023Q4 us-gaap Assets
Assets
7293000 usd
CY2024Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
128000 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
150000 usd
CY2024Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
394000 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
368000 usd
CY2024Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
41000 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
217000 usd
CY2024Q3 us-gaap Notes Payable Current
NotesPayableCurrent
53000 usd
CY2023Q4 us-gaap Notes Payable Current
NotesPayableCurrent
33000 usd
CY2024Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
12000 usd
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
18000 usd
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
628000 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
786000 usd
CY2024Q3 us-gaap Long Term Notes Payable
LongTermNotesPayable
170000 usd
CY2023Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
156000 usd
CY2024Q3 us-gaap Liabilities
Liabilities
798000 usd
CY2023Q4 us-gaap Liabilities
Liabilities
942000 usd
CY2024Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2024Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2024Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2024Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4403000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5259000 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
2127000 usd
us-gaap Operating Expenses
OperatingExpenses
5691000 usd
us-gaap Operating Expenses
OperatingExpenses
6406000 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-1951000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-4992000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-5996000 usd
CY2023Q3 us-gaap Investment Income Net
InvestmentIncomeNet
4000 usd
us-gaap Investment Income Net
InvestmentIncomeNet
48000 usd
us-gaap Investment Income Net
InvestmentIncomeNet
19000 usd
CY2023Q3 us-gaap Interest Expense Debt
InterestExpenseDebt
0 usd
us-gaap Interest Expense Debt
InterestExpenseDebt
15000 usd
us-gaap Interest Expense Debt
InterestExpenseDebt
0 usd
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
30000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0 usd
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
4000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
63000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
19000 usd
CY2024Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1513000 usd
us-gaap Net Income Loss
NetIncomeLoss
-4929000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-5977000 usd
us-gaap Net Income Loss
NetIncomeLoss
-5977000 usd
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
729400 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
586628 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
25315 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
25315 shares
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.07
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-55.93
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-8.40
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-236.10
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-236.10
us-gaap Net Income Loss
NetIncomeLoss
-4929000 usd
us-gaap Net Income Loss
NetIncomeLoss
-5977000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
115000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
104000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
246000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
467000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
2000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-4000 usd
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
28000 usd
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
0 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
121000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-34000 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-28000 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
7000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
85000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-150000 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
41000 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
3000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-22000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-393000 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
26000 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
111000 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-6000 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-29000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-4815000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-5547000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
69000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
114000 usd
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
28000 usd
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
0 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-41000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-114000 usd
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
1983000 usd
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
0 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
2998000 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
25000 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
44000 usd
us-gaap Proceeds From Repayments Of Notes Payable
ProceedsFromRepaymentsOfNotesPayable
-29000 usd
us-gaap Proceeds From Repayments Of Notes Payable
ProceedsFromRepaymentsOfNotesPayable
0 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
0 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
11000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1979000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
3031000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-2877000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-2630000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5395000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4775000 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2518000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2145000 usd
us-gaap Interest Paid Net
InterestPaidNet
15000 usd
us-gaap Interest Paid Net
InterestPaidNet
0 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
0 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
38000 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
10000 usd
CY2024Q3 snes Number Of States Registration Received
NumberOfStatesRegistrationReceived
50 state
CY2024Q3 snes Number Of States Approved Removal Of Restricted Use Designation
NumberOfStatesApprovedRemovalOfRestrictedUseDesignation
49 state
CY2024Q3 snes Number Of Major Us Territories Registration Received
NumberOfMajorUSTerritoriesRegistrationReceived
2 territory
CY2024Q3 snes Number Of Major U.S.Territories Authorized To Sell Product
NumberOfMajorU.S.TerritoriesAuthorizedToSellProduct
2 territory
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-134800000 usd
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2500000 usd
us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-top:12pt;padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts and classification of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements and reported amounts of revenues and expenses during the reporting period. </span></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The significant estimates in our financial statements include the valuation of inventory, common stock warrants, and stock-based awards, such as stock options and restricted stock units. Actual results could differ from such estimates.</span></div>
CY2024Q3 us-gaap Advertising Expense
AdvertisingExpense
58000 usd
CY2023Q3 us-gaap Advertising Expense
AdvertisingExpense
57000 usd
us-gaap Advertising Expense
AdvertisingExpense
180000 usd
us-gaap Advertising Expense
AdvertisingExpense
147000 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5400000 usd
CY2024Q3 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
218000 usd
CY2023Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
99000 usd
CY2024Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
4000 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
4000 usd
CY2024Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
214000 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
95000 usd
CY2024Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
4000 usd
CY2024Q3 us-gaap Allowance For Doubtful Accounts Receivable Period Increase Decrease
AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease
0 usd
CY2023Q3 us-gaap Allowance For Doubtful Accounts Receivable Period Increase Decrease
AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease
2000 usd
us-gaap Allowance For Doubtful Accounts Receivable Period Increase Decrease
AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease
0 usd
us-gaap Allowance For Doubtful Accounts Receivable Period Increase Decrease
AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease
2000 usd
CY2024Q3 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
0 usd
CY2023Q3 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
4000 usd
us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
0 usd
us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
6000 usd
CY2024Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
4000 usd
CY2023Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
2000 usd
CY2024Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
4000 usd
CY2023Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
2000 usd
CY2024Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
765000 usd
CY2023Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
747000 usd
CY2024Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
115000 usd
CY2023Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
53000 usd
CY2024Q3 us-gaap Inventory Gross
InventoryGross
880000 usd
CY2023Q4 us-gaap Inventory Gross
InventoryGross
800000 usd
CY2024Q3 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
0 usd
CY2023Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
5000 usd
CY2024Q3 us-gaap Inventory Net
InventoryNet
880000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
795000 usd
CY2024Q2 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
0 usd
CY2023Q2 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
18000 usd
CY2024Q3 snes Inventory Valuation Reserves Additions
InventoryValuationReservesAdditions
0 usd
CY2023Q3 snes Inventory Valuation Reserves Additions
InventoryValuationReservesAdditions
0 usd
snes Inventory Valuation Reserves Additions
InventoryValuationReservesAdditions
0 usd
snes Inventory Valuation Reserves Additions
InventoryValuationReservesAdditions
0 usd
CY2024Q3 snes Inventory Valuation Reserves Amount Relieved
InventoryValuationReservesAmountRelieved
0 usd
CY2023Q3 snes Inventory Valuation Reserves Amount Relieved
InventoryValuationReservesAmountRelieved
0 usd
snes Inventory Valuation Reserves Amount Relieved
InventoryValuationReservesAmountRelieved
5000 usd
snes Inventory Valuation Reserves Amount Relieved
InventoryValuationReservesAmountRelieved
0 usd
CY2024Q3 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
0 usd
CY2023Q3 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
18000 usd
CY2024Q3 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
0 usd
CY2023Q3 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
18000 usd
CY2024Q3 snes Prepaid Equity Offering Costs Current
PrepaidEquityOfferingCostsCurrent
132000 usd
CY2023Q4 snes Prepaid Equity Offering Costs Current
PrepaidEquityOfferingCostsCurrent
0 usd
CY2024Q3 snes Prepaid Software Licenses Current
PrepaidSoftwareLicensesCurrent
82000 usd
CY2023Q4 snes Prepaid Software Licenses Current
PrepaidSoftwareLicensesCurrent
152000 usd
CY2024Q3 us-gaap Prepaid Insurance
PrepaidInsurance
52000 usd
CY2023Q4 us-gaap Prepaid Insurance
PrepaidInsurance
64000 usd
CY2024Q3 snes Professional Services Retainer
ProfessionalServicesRetainer
30000 usd
CY2023Q4 snes Professional Services Retainer
ProfessionalServicesRetainer
30000 usd
CY2024Q3 us-gaap Prepaid Rent
PrepaidRent
29000 usd
CY2023Q4 us-gaap Prepaid Rent
PrepaidRent
11000 usd
CY2024Q3 snes Prepaid Inventory Current
PrepaidInventoryCurrent
0 usd
CY2023Q4 snes Prepaid Inventory Current
PrepaidInventoryCurrent
111000 usd
CY2024Q3 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
35000 usd
CY2023Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
20000 usd
CY2024Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
360000 usd
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
388000 usd
CY2024Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2201000 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2419000 usd
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
380000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
388000 usd
CY2024Q3 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
377000 usd
CY2023Q4 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
232000 usd
CY2024Q3 snes Legal Services Current
LegalServicesCurrent
14000 usd
CY2023Q4 snes Legal Services Current
LegalServicesCurrent
121000 usd
CY2024Q3 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
3000 usd
CY2023Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
15000 usd
CY2024Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
394000 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
368000 usd
CY2024Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
57000 usd
CY2023Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
55000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
170000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
166000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
41000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
41000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
0 usd
CY2024Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
41000 usd
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4533 shares
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
899.48
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P3Y9M18D
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
143312 shares
CY2024Q3 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
2.81
CY2024Q3 snes Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Remaining Contractual Term
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm
P9Y10M24D
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
9 shares
CY2024Q3 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
45013.33
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
147836 shares
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
27.56
CY2024Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P9Y8M12D
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3643 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1197
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
144204 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
2.83
snes Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Remaining Contractual Term
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm
P9Y10M24D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
2 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
1965.36
snes Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures Weighted Average Remaining Contractual Term
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresWeightedAverageRemainingContractualTerm
P3Y
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
9 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
45013.33
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
147836 shares
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
27.56
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P9Y8M12D
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
6274 shares
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
557.32
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P5Y9M18D
CY2024Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
73000 usd
CY2023Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
131000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
246000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
467000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
6351000 usd
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
85000 usd
CY2024Q1 snes Stock Issued During Period Value Warrants Exercised
StockIssuedDuringPeriodValueWarrantsExercised
6000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-1832000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
4610000 usd
CY2024Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
88000 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-1584000 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
3114000 usd
CY2024Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
73000 usd
CY2024Q3 snes Stock Issued During Period Value Warrants Exercised
StockIssuedDuringPeriodValueWarrantsExercised
1977000 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-1513000 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
3651000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
5279000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
166000 usd
CY2023Q1 us-gaap Restricted Stock Value Shares Issued Net Of Tax Withholdings
RestrictedStockValueSharesIssuedNetOfTaxWithholdings
-11000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
100000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-2037000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
3497000 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
113000 usd
CY2023Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1210000 usd
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
88000 usd
CY2023Q3 snes Stock Issued During Period Value Warrants Exercised
StockIssuedDuringPeriodValueWarrantsExercised
1788000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-1947000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
2756000 usd
CY2024Q2 snes Shelf Registration Future Offering Availability Amount
ShelfRegistrationFutureOfferingAvailabilityAmount
1575944 usd
CY2024Q3 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
315189 shares
CY2023Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
777528 shares
snes Class Of Warrant Or Right Issued
ClassOfWarrantOrRightIssued
1036279 shares
snes Class Of Warrant Or Right Exercised
ClassOfWarrantOrRightExercised
505962 shares
snes Class Of Warrant Or Right Expired
ClassOfWarrantOrRightExpired
3 shares
CY2024Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
1307842 shares
CY2023Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
777528 shares
CY2023Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
29.53
CY2023 snes Class Of Warrant Or Right Outstanding Weighted Average Remaining Contractual Term
ClassOfWarrantOrRightOutstandingWeightedAverageRemainingContractualTerm
P3Y4M24D
snes Class Of Warrant Or Right Issued
ClassOfWarrantOrRightIssued
1036279 shares
CY2024Q3 snes Class Of Warrant Or Right Exercise Price Of Warrants Or Rights Issued
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRightsIssued
4.38
snes Class Of Warrant Or Right Issued Weighted Average Remaining Contractual Term Issued
ClassOfWarrantOrRightIssuedWeightedAverageRemainingContractualTermIssued
P3Y4M24D
snes Class Of Warrant Or Right Exercised
ClassOfWarrantOrRightExercised
505962 shares
CY2024Q3 snes Class Of Warrant Or Right Exercise Price Of Warrants Or Rights Exercised
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRightsExercised
4.61
snes Class Of Warrant Or Right Expired
ClassOfWarrantOrRightExpired
3 shares
CY2024Q3 snes Class Of Warrant Or Right Exercise Price Of Warrants Or Rights Expired
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRightsExpired
81000
CY2024Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
1307842 shares
CY2024Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
12.63
snes Class Of Warrant Or Right Outstanding Weighted Average Remaining Contractual Term
ClassOfWarrantOrRightOutstandingWeightedAverageRemainingContractualTerm
P3Y3M18D
CY2024Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
43889 shares
CY2023Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
25938 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
454619 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
332034 shares
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 segement
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
482000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
360000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1356000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
898000 usd
CY2024Q3 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2024Q3 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0001628280-24-047314-index-headers.html Edgar Link pending
0001628280-24-047314-index.html Edgar Link pending
0001628280-24-047314.txt Edgar Link pending
0001628280-24-047314-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
snes-20240930_lab.xml Edgar Link unprocessable
snes-20240930_cal.xml Edgar Link unprocessable
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
snes-20240930.htm Edgar Link pending
snes-20240930.xsd Edgar Link pending
snes-20240930xex311.htm Edgar Link pending
snes-20240930xex312.htm Edgar Link pending
snes-20240930xex321.htm Edgar Link pending
snes-20240930xex322.htm Edgar Link pending
snes-20240930_def.xml Edgar Link unprocessable
snes-20240930_pre.xml Edgar Link unprocessable
snes-20240930_htm.xml Edgar Link completed